Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3093-3104

  De La Monte, Suzanne M ^a,e   Ghanbari, Kasra ^b   Frey, William H ^c   Beheshti, Iraj ^b   Averback, Paul ^b   Hauser, Stephen L ^d   Ghanbari, Hossein A ^b   Wands, Jack R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Nymox Corporation   (United States)

^c Ramsey Alzheimer's Treatm Res Ctr   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AD7c NTP; Alu sequence; Alzheimer's Disease; Cerebrospinal fluid; Enzyme immunoassay; Neurodegeneration

Indexed keywords

COMPLEMENTARY DNA;

ALU SEQUENCE; ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMENTIA; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

EID: 0031439777     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci119864     Document Type: Article

References (52)

1. Khachaturian, Z.S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1105.
2. Takman, A. 1993. Epidemiology of Alzheimer's disease. Issues of etiology and validity. Acta. Neurol. Scand. 145(Suppl.):1-70.
3. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:921-925.
4. Lai, F., and R.S. Williams. 1989. A prospective study of Alzheimer disease in Down syndrome. Arch. Neurol. 46:849-853.
5. Tanzi, R.E., G. Vaula, D.M. Romano, M. Mortilla, T.L. Huang, R.G. Tupler, W. Wasco, B.T. Hyman, J.L. Haines, B.J. Jenkins, et al. 1992. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51:273-282.
6. Levy-Lahad, E., W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell, C.E. Yu, P.D. Jondro, S.D. Schmidt, K. Wang, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 18:973-977.
7. Sorb, S., B. Nacmias, P. Forleo, S. Piacentini, R. Sherrington, E. Rogaev, P. St. George-Hyslop, and L. Amaducci. 1995. Missense mutation of S182 gene in Italian families with early onset Alzheimer's disease. Lancet (N. Am. Ed.). 346:439-440.
8. Sherrington, R., E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375: 754-760.
9. Rogaev, E.I., R. Sherrington, E.A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang, H. Chi, C. Lin, K. Holman, T. Tsuda, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:775-778.
10. Barinaga, M. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:973-977.
11. Lai, F., and R.S. Williams. 1989. A prospective study of Alzheimer disease in Down syndrome. Arch. Neurol. 46:849-853.
12. LaFerla, F.M., B.T. Tinkle, C.J. Bieberich, C.C. Haudenschild, and G. Jay. 1995. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:21-30.
13. Lemere, C.A., F. Lopera, K.S. Kosik, C.L. Lendon, J. Ossa, T.C. Saido, H. Yamaguchi, A. Ruiz, A. Martinez, L. Madrigal, et al. 1996. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2:1146-1150.
14. Grundke-Iqbal, I., K. Iqbal, Y.C. Tung, M. Quintan, H.M. Wisniewski, and L.I. Binder. 1986. Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:4913-4917.
15. de la Monte, S.M., S.C. Ng, and D.W. Hsu. 1995. Aberrant GAP-43 gene expression in Alzheimer's disease. Am. J. Pathol. 147:934-946.
16. de la Monte, S.M., and K.D. Bloch. 1997. Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer Disease. Mol. Chem. Neuropathol. 30:139-159.
17. Peress, N.S., and E. Perillo. 1995. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54:802-811
18. Aschner, M. 1996. The functional significance of brain metallothioneins. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:1129-1136.
19. Goodison, K.L., I.M. Parhad, C.L. White, A.A. Sima, and A.W. Clark. 1993. Neuronal and glial gene expression in neocortex of Down's syndrome. J. Neuropathol. Exp. Neurol. 52:192-198.
20. Pasternack, J.M., C.R. Abraham, B.J. Van Dyke, H. Potter, and S.G. Younkin. 1989. Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. Am. J. Pathol. 135:827-834.
21. May, P.C., M. Lampert-Etchells, S.A. Johnson, J. Poirier, J.N. Masters, and C.E. Finch. 1990. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron. 5:831-839.
22. Cataldo, A.M., J.L. Barnett, S.A. Berman, J. Li, S, Quarless, S. Bursztajn, C. Lippa, and R.A. Nixon. 1995. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 14:671-680.
23. Somerviile, M.J, M.E. Percy, C. Bergeron, L.K. Yoong, E.A. Grima, and D.R. McLachlan. 1991. Localization and quantitation of 68 kDa neurofilament and Superoxide dismutase-1 mRNA in Alzheimer brains. Mol. Brain. Res. 9:1-8.
24. Chandrasekaran, K., T. Giordano, D.R. Brady, J. Stoll, L.J. Martin, and S.I. Rapoport. 1994. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol. Brain. Res. 24:336-340.
25. Fischer, B., H. Schmoll, P. Riederer, J. Bauer, D. Platt, and D. PopaWagner. 1995. Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients. J. Mol. Med. 73:465-471.
26. Yamagishi, M., S. Takami, and T.V. Getchell. 1996. Ontogenetic expression of spot 35 protein (calbindin-D28k) in human olfactory receptor neurons and its decrease in Alzheimer's disease patients. Ann. Otol. Rhinol. Laryngol. 105:132-139.
27. O'Barr, S., J. Schultz, and J. Rogers. 1996. Expression of the protooncogene bcl-2 in Alzheimer's disease brain. Neurubiol. Aging. 17:131-136.
28. de la Monte, S.M., M. Ozturk, and J.R. Wands. 1990. Enhanced expression of an exocrine pancreatic protein in Alzheimer's disease and the developing human brain. J. Clin. Invest. 86:1004-1013.
29. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. 1997. Current Protocols in Molecular Biology. John Wiley & Sons, New York.
30. de la Monte, S.M., R.I. Carlson, N.V. Brown, and J.R. Wands. 1996. Profiles of neuronal thread protein expression in Alzheimer's disease. J. Neuropath. Exp. Neurol. 55:1038-1050.
31. Mirra, S.S., A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, L. Berg, et al. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 41:479-486.
32. Lee, R.T., K.D. Bloch, J.M. Pfeffer, M.A. Pfeffer, E.J. Neer, and C.E. Seidman. 1988. Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J. Clin. Invest. 81:431-434.
33. Dallman, M.J., and A.C.G. Porter. 1991. Semi-quantitative PCR for the analysis of gene expression. In PCR A Practical Approach. M.J. McPherson, P. Quirke, and G.F. Taylor, editors. IRL Press at Oxford University Press, Oxford. 215-224.
34. McKhann, G., D.A. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:939-944.
35. Bellet, D.H., M. Ozturk, J.M. Bidart, C.J. Bohouon, and J.R. Wands. 1988. Sensitive and specific assay for human chorionic gonadutropin based on anti-peptide and anti-glycoprotein monoclonal antibodies: construction and clinical implications. J. Clin. Endocrinol. Metab. 63:1319-1327.
36. Ozturk, M., D. Bellet, L. Manil, G. Hennen, R. Frydmann, and J.R. Wands. 1987. Physiologic studies of hCG, αhCG, and βhCH as measured by specific monoclonal immunoradiometric assays. Endocrinology. 120:549-558.
37. Biedler, J.L., L. Helson, and B.A. Sprengler. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652.
38. The, I., A.E. Murthy, G.E. Hannigan, L.B. Jacoby, A.G. Menon, J.F. Gusella, and A. Bernards. 1993. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat. Genet. 3:2643-2642.
39. Singer, M.F. 1982. Highly repeated sequences in mammalian genomes. Int. Rev. Cytol. 76:67-112.
40. Sakamoto K., C.M. Fordis, C.D. Corsico, T.H. Howard, and B.H. Howard. 1991. Modulation of HeLa Cell growth by transfected 7SL RNA and Alu gene sequences. J. Biol. Chem. 266:3031-3038.
41. - merase III transcription in response to F9 embryonal carcinoma stem cell differentiation. Cell. 59:1081-1092.
42. Howard, B.H., and K. Sakamolo. 1990. Alu interspersed repeats: selfish DNA or a functional gene family? New Biol. 2:759-770.
43. Li, L., and P.F. Bray. 1993. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am. J. Hum. Genet. 53:140-149.
44. Kornreich, R., D.F. Bishop, and R.J. Desnick. 1990. Alpha-galactosidase A gene rearrangements causing Fabry disease. J. Biol. Chem. 265:9319-9326.
45. Shimada, F., M. Tairs, Y. Suzuki, N. Hashimoto, O. Nozaki, M. Taira, M. Tatibana, Y. Ebins, M. Tawata, T. Onaya, H. Makino, and S. Yoshida. 1990. Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet (N. Am. Ed.). 335:1179-1181.
46. Lehrman, M.A., D.W. Russell, J.I. Goldstein, and M.S. Brown. 1987. Alu-Alu recombination deletes splice acceptor sites and produces secreted low density lipoprotein receptor in a subject with familial hypercholesterolemia. J. Biol. Chem. 262:3354-3361.
47. Wallace, M.R., L.B. Andersen, A.M. Saulino, P.E. Gregory, T.W. Glover, and F.S. Collins. 1991. A de novo Alu insertion results in neurofibromatosis type 1. Nature. 353:864-866.
48. De Kosky, S., and S.W. Scheff. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27: 457-464.
49. McKee, A.C., K.S. Kosik, and N.W. Kowall. 1991. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:156-165.
50. Su, J.H., A.J. Anderson, B.J. Cummings, and C.W. Cotman. 1994. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:2529-2533.
51. Smale, G., N.R. Nichols, D.R. Brady, C.E. Finch, and W.E. Horton, Jr. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol. 133:225-230.
52. de la Monte, S.M., Y-K. Sohn, and J.R. Wands. 1997. p53 and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. In press.